comparemela.com

Latest Breaking News On - National psychiatry conference - Page 1 : comparemela.com

Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Luye pharma groupPrnewswire luye pharma groupPharma groupAnsofaxine hydrochloride extended release tabletsNational psychiatry conferenceChinese medicalNew chemical entityNew drug applicationMajor depressive disorderHamilton depression rating scalePr newswireClinical trials

Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets

/PRNewswire/ Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine.

United statesZhang hongyanLuye pharmaLuye pharma groupChinese medical multimediaClinical research at luye pharma groupUniversity sixth hospitalAnsofaxine hydrochloride extended release tabletsNational psychiatry conferenceChinese medicalNew chemical entityNew drug applicationMajor depressive disorderHamilton depression rating scaleSomatic anxiety factorSomatization factor

Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets

/PRNewswire/ Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine.

United statesZhang hongyanLuye pharmaLuye pharma groupChinese medical multimediaClinical research at luye pharma groupUniversity sixth hospitalAnsofaxine hydrochloride extended release tabletsNational psychiatry conferenceChinese medicalNew chemical entityNew drug applicationMajor depressive disorderHamilton depression rating scaleSomatic anxiety factorSomatization factor

vimarsana © 2020. All Rights Reserved.